OUR MISSION

The mission of ID Bayview is to:
  • train innovative researchers and clinicians
  • provide excellent, ethical and compassionate care
  • deliver education to our diverse communities and patients from a public health perspective
  • promote pioneering translational research and discovery to advance the prevention and treatment of infectious diseases.

 

STAY CONNECTED

Twitter You Tube

ANNOUNCEMENT: NEXT DIRECTOR OF INFECTIOUS DISEASES AT BAYVIEW

Department of Medicine — From the office of the director

We are thrilled to announce that Mark Sulkowski, M.D. will be the next Director of the Division of Infectious Diseases at Bayview beginning on October 8, 2019. Dr. Sulkowski will lead the clinical, research and educational activities at Bayview and aims to expand and build new clinical and research programs that leverage core strengths of the Bayview environment, including geriatrics, the National Institute of Aging, and rheumatology.

Dr. Sulkowski is a Professor of Medicine and serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He also serves as the Associate Dean for Research in the Capital Region (CAPRES) for Johns Hopkins Medicine.

He has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He is the immediate past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) leading translational studies of liver disease, namely hepatitis B, hepatitis C, and fatty liver disease. He is an elected member of the American Society for Clinical Investigation and the American Association of Physicians. He is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). He is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Journal of Infectious Diseases, Journal of Hepatology, and Hepatology.

Dr. Sulkowski received his M.D. degree from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995), and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine.

We are thrilled that Dr. Sulkowski will be leading the division, which is now completely integrated with the Broadway ID Division directed by Dr. Thomas. We are also extremely grateful to Khalil Ghanem, MD, PhD for his outstanding service as interim Director of Infectious Diseases since July.

Please join us in welcoming Mark to his new role.

Thank you,


David B. Hellmann, M.D., M.A.C.P.
Aliki Perroti Professor of Medicine
Vice-Dean, Johns Hopkins Bayview
Johns Hopkins University School of Medicine
Chairman, Department of Medicine
Johns Hopkins Bayview Medical Center


Mark E. Anderson, M.D., Ph.D.
William Osler Professor of Medicine
Director, Department of Medicine
Physician-in-Chief, Johns Hopkins Hospital
Director of Medicine for Johns Hopkins Medicine


David L. Thomas, M.D., M.P.H.
Stanhope Bayne-Jones Professor of Medicine
Chief, Division of Infectious Diseases
John Hopkins University, School of Medicine